Back

Intensive lipid lowering therapy improves microvascular function assessed by retinal vessel analysis in patients after ST-elevation myocardial infarction

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (2) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor David Hanke

University hospital Jena, Jena (Germany)

5 More presentations in this session

Presentation thumbnail
Longitudinal trends in statin prescribing and LDL-C control prior to acute myocardial infarction (AMI) in France: we continue to “miss the mark”
Doctor P. PIRIOU (Paris, FR)
Abstract Slides
Presentation thumbnail
Sex- and age-based disparities in statin use in patients admitted for acute myocardial infarction in France: two decades of failure ?
Doctor P. PIRIOU (Paris, FR)
Abstract Slides
Presentation thumbnail
Association between remnant cholesterol levels and the in-hospital outcomes and long-term prognosis in ST-segment elevated myocardial infarction patients
Ms H. Chen (CN)
Abstract Slides
Presentation thumbnail
Aspirin for primary prevention in patients with diabetes according to lipoprotein(a) levels: a real-world propensity-matched analysis
Doctor A. Askarinejad (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Changes in lipoprotein(a) levels in younger patients following ST-elevation myocardial infarction
Doctor J. Yoon (Vancouver, CA)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Endothelial function improvement associated with the new European Society of Cardiology LDL target levels in STEMI patients
18 March 2022
thumbnail
Congress Presentation
Retinal neurovascular changes in heart failure with preserved ejection fraction: an optical coherence tomography angiography pilot study
21 May 2023
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021
thumbnail
Congress Presentation
Predictor factors of microvascular obstruction in early presenters of ST-segment elevation myocardial infarction
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources